Global Extracorporeal Membrane Oxygenation Machine Market 2022-2032

1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations

2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations

3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Extracorporeal Membrane Oxygenation Machine Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends

4.1. Extracorporeal Membrane Oxygenation Machine Market, by Key Countries
4.2. Extracorporeal Membrane Oxygenation Machine Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Extracorporeal Membrane Oxygenation Machine Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Extracorporeal Membrane Oxygenation Machine Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking

6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis

8.1. Introduction/Key Findings
8.2. Historical Market Value (US$ Mn) and Analysis By Component, 2015-2021
8.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Component, 2022-2032
8.3.1. Pumps
8.3.2. Oxygenators
8.3.3. Controllers
8.3.4. Cannul
8.3.5. Assessories
8.4. Market Attractiveness Analysis By Component

9.1. Introduction/Key Findings
9.2. Historical Market Value (US$ Mn) and Analysis By Product , 2015-2021
9.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Product , 2022-2032
9.3.1. ECMO Machines
9.3.1.1. Portable Devices
9.3.1.2. Static Devices
9.3.2. Software
9.4. Market Attractiveness Analysis By Product

10.1. Introduction/Key Findings
10.2. Historical Market Value (US$ Mn) and AnalysisBy Provider, 2015-2021
10.3. Current and Future Market Value (US$ Mn) and Analysis and ForecastBy Provider, 2022-2032
10.3.1. Application
10.3.2. Middleware
10.3.3. Infrastructure
10.4. Market Attractiveness AnalysisBy Provider

11.1. Introduction/Key Findings
11.2. Historical Market Value (US$ Mn) and Analysis By Modality , 2015-2021
11.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Modality , 2022-2032
11.3.1. Veno-Venous
11.3.2. Veno-Arterials
11.3.3. Arterio-Venous
11.4. Market Attractiveness Analysis By Modality

12.1. Introduction/Key Findings
12.2. Historical Market Value (US$ Mn) and Analysis By Patient Type , 2015-2021
12.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Patient Type , 2022-2032
12.3.1. Neonates
12.3.2. Pediatrics
12.3.3. Adults
12.4. Market Attractiveness Analysis By Patient Type

13.1. Introduction
13.2. Historical Market Value (US$ Mn) and Analysis By Region, 2015-2021
13.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. Asia Pacific
13.3.5. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.1.3. Rest of North America
14.4.2. By Provider
14.4.3. By Component
14.4.4. By Product
14.4.5. By Modality
14.4.6. By Patient Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Provider
14.5.3. By Component
14.5.4. By Product
14.5.5. By Modality
14.5.6. By Patient Type

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Brazil
15.4.1.2. Mexico
15.4.1.3. Rest of Latin America
15.4.2. By Provider
15.4.3. By Component
15.4.4. By Product
15.4.5. By Modality
15.4.6. By Patient Type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Provider
15.5.3. By Component
15.5.4. By Product
15.5.5. By Modality
15.5.6. By Patient Type

16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. France
16.4.1.3. U.K.
16.4.1.4. Italy
16.4.1.5. Russia
16.4.1.6. Rest of Europe
16.4.2. By Provider
16.4.3. By Component
16.4.4. By Product
16.4.5. By Modality
16.4.6. By Patient Type
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Provider
16.5.3. By Component
16.5.4. By Product
16.5.5. By Modality
16.5.6. By Patient Type

17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. China
17.4.1.2. Japan
17.4.1.3. South Korea
17.4.1.4. Rest of Asia Pacific
17.4.2. By Provider
17.4.3. By Component
17.4.4. By Product
17.4.5. By Modality
17.4.6. By Patient Type
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Provider
17.5.3. By Component
17.5.4. By Product
17.5.5. By Modality
17.5.6. By Patient Type

18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
18.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
18.4.1. By Country
18.4.1.1. GCC Countries
18.4.1.2. South Africa
18.4.1.3. Turkey
18.4.1.4. Rest of Middle East and Africa
18.4.2. By Provider
18.4.3. By Component
18.4.4. By Product
18.4.5. By Modality
18.4.6. By Patient Type
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Provider
18.5.3. By Component
18.5.4. By Product
18.5.5. By Modality
18.5.6. By Patient Type

19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. US Extracorporeal Membrane Oxygenation Machine Market Analysis
19.2.1. Value Proportion Analysis by Market Taxonomy
19.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.2.2.1. By Provider
19.2.2.2. By Component
19.2.2.3. By Product
19.2.2.4. By Modality
19.2.2.5. By Patient Type
19.3. Canada Extracorporeal Membrane Oxygenation Machine Market Analysis
19.3.1. Value Proportion Analysis by Market Taxonomy
19.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.3.2.1. By Provider
19.3.2.2. By Component
19.3.2.3. By Product
19.3.2.4. By Modality
19.3.2.5. By Patient Type
19.4. Mexico Extracorporeal Membrane Oxygenation Machine Market Analysis
19.4.1. Value Proportion Analysis by Market Taxonomy
19.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.4.2.1. By Provider
19.4.2.2. By Component
19.4.2.3. By Product
19.4.2.4. By Modality
19.4.2.5. By Patient Type
19.5. Brazil Extracorporeal Membrane Oxygenation Machine Market Analysis
19.5.1. Value Proportion Analysis by Market Taxonomy
19.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.5.2.1. By Provider
19.5.2.2. By Component
19.5.2.3. By Product
19.5.2.4. By Modality
19.5.2.5. By Patient Type
19.6. Germany Extracorporeal Membrane Oxygenation Machine Market Analysis
19.6.1. Value Proportion Analysis by Market Taxonomy
19.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.6.2.1. By Provider
19.6.2.2. By Component
19.6.2.3. By Product
19.6.2.4. By Modality
19.6.2.5. By Patient Type
19.7. France Extracorporeal Membrane Oxygenation Machine Market Analysis
19.7.1. Value Proportion Analysis by Market Taxonomy
19.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.7.2.1. By Provider
19.7.2.2. By Component
19.7.2.3. By Product
19.7.2.4. By Modality
19.7.2.5. By Patient Type
19.8. Italy Extracorporeal Membrane Oxygenation Machine Market Analysis
19.8.1. Value Proportion Analysis by Market Taxonomy
19.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.8.2.1. By Provider
19.8.2.2. By Component
19.8.2.3. By Product
19.8.2.4. By Modality
19.8.2.5. By Patient Type
19.9. Russia Extracorporeal Membrane Oxygenation Machine Market Analysis
19.9.1. Value Proportion Analysis by Market Taxonomy
19.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.9.2.1. By Provider
19.9.2.2. By Component
19.9.2.3. By Product
19.9.2.4. By Modality
19.9.2.5. By Patient Type
19.10. UK Extracorporeal Membrane Oxygenation Machine Market Analysis
19.10.1. Value Proportion Analysis by Market Taxonomy
19.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.10.2.1. By Provider
19.10.2.2. By Component
19.10.2.3. By Product
19.10.2.4. By Modality
19.10.2.5. By Patient Type
19.11. China Extracorporeal Membrane Oxygenation Machine Market Analysis
19.11.1. Value Proportion Analysis by Market Taxonomy
19.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.11.2.1. By Provider
19.11.2.2. By Component
19.11.2.3. By Product
19.11.2.4. By Modality
19.11.2.5. By Patient Type
19.12. Japan Extracorporeal Membrane Oxygenation Machine Market Analysis
19.12.1. Value Proportion Analysis by Market Taxonomy
19.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.12.2.1. By Provider
19.12.2.2. By Component
19.12.2.3. By Product
19.12.2.4. By Modality
19.12.2.5. By Patient Type
19.13. South Korea Extracorporeal Membrane Oxygenation Machine Market Analysis
19.13.1. Value Proportion Analysis by Market Taxonomy
19.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.13.2.1. By Provider
19.13.2.2. By Component
19.13.2.3. By Product
19.13.2.4. By Modality
19.13.2.5. By Patient Type
19.14. GCC Countries Extracorporeal Membrane Oxygenation Machine Market Analysis
19.14.1. Value Proportion Analysis by Market Taxonomy
19.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.14.2.1. By Provider
19.14.2.2. By Component
19.14.2.3. By Product
19.14.2.4. By Modality
19.14.2.5. By Patient Type
19.15. South Africa Extracorporeal Membrane Oxygenation Machine Market Analysis
19.15.1. Value Proportion Analysis by Market Taxonomy
19.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.15.2.1. By Provider
19.15.2.2. By Component
19.15.2.3. By Product
19.15.2.4. By Modality
19.15.2.5. By Patient Type
19.16. Turkey Extracorporeal Membrane Oxygenation Machine Market Analysis
19.16.1. Value Proportion Analysis by Market Taxonomy
19.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.16.2.1. By Provider
19.16.2.2. By Component
19.16.2.3. By Product
19.16.2.4. By Modality
19.16.2.5. By Patient Type
19.16.3. Competition Landscape and Player Concentration in the Country

20.1. Market Analysis by Tier of Companies
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. By Regional footprint of Players
20.4.2. Product footprint by Players

21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. FRESENIUS MEDICAL CARE
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Sales Footprint
21.3.1.4. Strategy Overview
21.3.2. GETINGE GROUP
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Sales Footprint
21.3.2.4. Strategy Overview
21.3.3. MEDTRONIC PLC
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Sales Footprint
21.3.3.4. Strategy Overview
21.3.4. MICROPORT
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Sales Footprint
21.3.4.4. Strategy Overview
21.3.5. TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Sales Footprint
21.3.5.4. Strategy Overview
21.3.6. NIPRO CORPORATION
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Sales Footprint
21.3.6.4. Strategy Overview
21.3.7. LIVANOVA PLC
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Sales Footprint
21.3.7.4. Strategy Overview
21.3.8. EUROSETS S.R.L
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Sales Footprint
21.3.8.4. Strategy Overview
21.3.9. ORIGEN BIOMEDICAL, INC
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Sales Footprint
21.3.9.4. Strategy Overview
21.3.10. CYTOSORBENTS CORPORATION
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Sales Footprint
21.3.10.4. Strategy Overview